Effect of physcion on proliferation and glycolysis of liver cancer cells and its mechanismTAO Zhengdi, WU Qinyan, LAN Xiaohong, GAO Ming, WEI Wei, XIE Xuejian, WANG Yuekun769-775
Expression of CMTM6 in gastric cancer tissues and its relationship with PD-L1 and prognosisLI Jia, JI Gao, SUN Xu, ZHANG Lu, LIU Huaimin776-781
Clinical investigation of PD-1/PD-L1 inhibitors associated acute renal injury in patients with primary non-small cell lung cancerDU Ye, FU Luyu, GUO Yidan, LUO Yang782-787
Expression and prognostic significance of miR-217 in patients with gastric cancer:the Cancer Genome Atlas Database based studyZHENG Xia, SHAO Jie, GU Yu, PAN Yu788-793
Efficacy of chemotherapy as the first-line therapy in patients with advanced melanoma harboring NRAS mutationQI Zhonghui, WANG Xuan, MAO Lili, BAI Xue, CUI Chuanliang, SI Lu794-800
Efficacy evaluation and safety analysis of first-line chemotherapy versus chemotherapy combined with PD-1 monoclonal antibody in patients with advanced cholangiocarcinomaLI Yinglin, YE Sisi, QIAO Qian, BAI Li801-805
Value of dynamic contrast-enhanced magnetic resonance imaging in predicting response to chemoradio-therapy for locally advanced esophageal cancerGU Lingling, GUO Zhen, SHEN Wenrong, XIE Xiaodong, QIAN Pudong, JIANG Ning806-812
Predictive value of PNI and SⅡ for prognosis of colorectal cancer patients with stage Ⅲ and ⅣLI Yizhuo, WU Chengli, YU Xihao813-817
Clinicopathological analysis of 34 cases of internal fibroadenomatous carcinoma of the breastDAI Ran, DILIZHAWAER·Hailaiti, LUO Lin, ZHAO Ya'nan, ALIBIYATI·Aini818-822
Apedigree study of Lynch syndrome and pathogenic analysis of MLH1 geneHUANG Wei, GU Ruidong, ZHANG Yu, ZHANG Wei, ZOU Xi, QIAN Xiaoping, WANG Lin823-828
